Current gene therapy approaches for Parkinson's disease primarily aim to:
-
A
Replace the entire population of lost dopaminergic neurons at once
-
B
Deliver genes that enhance dopamine synthesis or provide neuroprotective factors
-
C
Edit the SNCA gene in all cells of the body simultaneously
-
D
Introduce foreign genetic material into the immune system